Mice receiving orally catalase-producing Lactococcus lactis have been shown to have significantly less colonic damage and inflammation and prevent tumorigenesis compared to animals not receiving catalase-producing L. lactis or bacterial supplementation in an experimental DMH-induced colon cancer mouse model [151]. Here, CAT is linked to colonic neoplasm.